As the demand for low-calorie sweeteners and rare sugars continues to grow, D-tagatose powder has emerged as one of the most promising alternatives to sucrose in modern food formulation. Food manufacturers worldwide are increasingly using this rare sugar because of its low glycemic impact, reduced calorie content, and excellent taste profile.
For food ingredients entering the U.S. market, regulatory approval is essential. In the United States, D-tagatose has been reviewed under multiple FDA GRAS (Generally Recognized as Safe) notices, confirming its safety for use in a wide range of food products. Check this article for details on the applications of D-tagatose.
This article explains the FDA GRAS status of D-tagatose, focusing on the three major notices:
These notices collectively establish the regulatory foundation for the use of D-tagatose in foods and beverages.
What Is FDA GRAS?
The Generally Recognized as Safe (GRAS) designation allows certain food ingredients to be used in foods without pre-market approval if qualified experts determine that the ingredient is safe under its intended conditions of use.
A GRAS determination typically includes evaluation of:
- Chemical identity and composition
- Manufacturing process
- Intended food applications
- Estimated dietary exposure
- Toxicological and clinical safety studies
Independent scientific experts review the available evidence to determine whether the ingredient meets GRAS criteria.
D-tagatose has undergone this evaluation multiple times through different GRAS notices submitted to the FDA.
Overview of the Three D-Tagatose GRAS Notices
Three major GRAS notices related to D-tagatose have been submitted to the U.S. FDA.
| GRAS Notice | Company | Key Purpose |
|---|---|---|
| GRN 78 | Arla Foods Ingredients | Initial GRAS determination for D-tagatose |
| GRN 352 | CJ CheilJedang | Expanded food applications |
| GRN 977 | Bonumose | New enzymatic manufacturing process |
The FDA responded with “no questions” letters, indicating that the agency had no objections to the GRAS conclusions under the intended conditions of use.
GRN 78: Initial FDA GRAS Determination for D-Tagatose
GRN 78 was one of the earliest GRAS notices establishing the safety of D-tagatose for use as a bulk sweetener in reduced-calorie foods.
The submission included comprehensive data on:
- Chemical properties
- Manufacturing process
- Toxicological safety
- Estimated dietary intake
The ingredient was proposed for use in foods such as:
- Diet carbonated beverages
- Ready-to-eat breakfast cereals
- Icings and frostings
- Frozen dairy desserts
- Sugar-free chewing gum
- Nutritional bars
- Meal replacement products
These applications demonstrate the versatility of D-tagatose as a functional sugar substitute in multiple food categories.
Estimated intake data showed that even heavy consumers would ingest amounts well below levels associated with adverse effects. Mean consumption was estimated at approximately 6.6 g per day, while high consumers could reach about 14.9 g per day.
GRN 352: Expanded Food Applications of D-Tagatose
GRN 352 was submitted later to expand the use of D-tagatose across additional food categories.
The notice describes D-tagatose as a ketohexose and epimer of fructose, with sweetness close to sucrose.
D-tagatose provides approximately 1.5 kcal per gram, significantly lower than conventional sugars.
Additional proposed applications included:
- Non-diet soft drinks
- Confectionery products
- Yogurt
- Ice cream and frozen yogurt
- Cakes and baked goods
- Coffee mix powders
- Cookies and biscuits
- Cereal bars
An independent expert panel reviewed the available scientific data and concluded that D-tagatose is safe for its intended food uses, supporting the GRAS determination.
Estimated intake calculations suggested an average daily intake of about 16.2 g, with high consumers reaching 38.9 g per day, still within safe levels for the general population.
GRN 977: Novel Enzymatic Manufacturing Process
GRN 977 introduced an updated production technology for D-tagatose using an advanced enzymatic cascade process.
The notice focuses primarily on:
- Enzyme engineering and fermentation
- Purification and immobilization technologies
- Product quality control and specifications
- Toxicology and human safety studies
The scientific review included:
- Animal studies
- In-vitro safety tests
- Human clinical studies
- Gastrointestinal tolerance assessments
These evaluations confirmed that the newly produced D-tagatose is equivalent in safety and composition to previously approved versions.
Importantly, the notice confirms that D-tagatose continues to be GRAS for use in foods and beverages under the previously established conditions.
Functional Properties of D-Tagatose
Beyond regulatory approval, D-tagatose offers several technological advantages in food formulation.
Key properties include:
Sweetness
D-tagatose provides approximately 90% of the sweetness of sucrose, allowing manufacturers to replace sugar while maintaining a similar taste profile.
Low Calorie Value
Because it is only partially digested in the small intestine, D-tagatose provides around 1.5 kcal per gram.
Prebiotic Potential
Unabsorbed D-tagatose can be fermented by gut microbiota, producing short-chain fatty acids that support digestive health.
Dental Health Benefits
Studies show that D-tagatose is non-cariogenic, meaning it does not promote tooth decay.
Glycemic Response
Unlike conventional sugars, D-tagatose has minimal impact on blood glucose levels.
These properties make it suitable for:
- diabetic-friendly foods
- low-calorie beverages
- functional nutrition products
Global Regulatory Status of D-Tagatose
In addition to FDA GRAS recognition, D-tagatose has received approvals from several international regulatory authorities.
These include:
- European Food Safety Authority (EFSA) – approved as a novel food ingredient
- Health Canada – licensed as a Natural Health Product
- JECFA (Joint FAO/WHO Expert Committee on Food Additives) – assigned an ADI of “not specified,” indicating a high safety margin.
This broad regulatory acceptance supports the global commercialization of D-tagatose in food and beverage products.
Why Food Manufacturers Are Adopting D-Tagatose
The FDA GRAS notices demonstrate that D-tagatose has undergone extensive scientific review and safety evaluation.
For food manufacturers, this rare sugar offers several advantages:
- Near-sugar taste profile
- Low glycemic impact
- Reduced calories
- Tooth-friendly properties
- Functional benefits in baking and confectionery
These features make D-tagatose an attractive ingredient for:
- sugar-reduction strategies
- diabetic-friendly foods
- functional nutrition products
- keto and low-carb formulations
BSH Ingredients: Leading D-Tagatose Supplier in China
As global demand for rare sugars and functional sweeteners continues to grow, BSH Ingredients supplies high-quality bulk D-tagatose to food manufacturers worldwide.
Our products are manufactured under strict quality control standards and are suitable for applications in:
- beverages
- dairy products
- bakery and confectionery
- nutritional supplements
- functional foods
With stable supply chains and international export experience, BSH Ingredients supports food innovators seeking reliable, rare-sugar solutions.
